Progressive Improvement in 5-Year Survival Rates for Extremity Soft Tissue Sarcomas from 1999 to 2019
Background. Extremity soft-tissue sarcoma (ESTS) is a group of rare, heterogeneous malignancies. Previous studies have demonstrated a progressive improvement in 5-year survival rate over time, but recent trends are unknown. Therefore, this study aimed to provide an update on the clinical characteris...
Main Authors: | Ryley K. Zastrow, Mohyeddine El Sayed, Christa L. LiBrizzi, Andrew J. Jacobs, Adam S. Levin |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2024-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2024/8880609 |
Similar Items
-
Injection granuloma mimicking soft tissue sarcoma following seasonal influenza vaccine administration
by: Gregory R. Toci, MD, et al.
Published: (2022-04-01) -
Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities
by: Alexander L. Lazarides, et al.
Published: (2018-04-01) -
Chemotherapy and Survival in Patients with Primary High-Grade Extremity and Trunk Soft Tissue Sarcoma
by: Danielle S. Graham, et al.
Published: (2020-08-01) -
DETECTION OF RECURRENT SOFT TISSUE SARCOMAS OF EXTREMITIES
by: G. V. Zinovyev, et al.
Published: (2017-06-01) -
Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas
by: Karen Voltan, et al.
Published: (2020-09-01)